Skip to content

Home
About
Investment Strategy
Portfolio
News
Contact

Enveda Biosciences Series B

January 20, 2023

Enveda Biosciences Closes $68-million Combined Series B Equity and Debt Financing

Investing in exceptional founders building the future.

Home
About
Portfolio
News
Contact

© 2026 AgileAngel. All rights reserved.